Mortality and drug therapy in patients with chronic obstructive pulmonary disease: a network meta-analysis
Conclusion:
Results of an NMA of COPD treatments suggest that SFC and indacaterol may reduce mortality. Further research is warranted to strengthen this conclusion.
Source: BMC Pulmonary Medicine - Category: Respiratory Medicine Authors: David A ScottBethan WoodsJuliette C ThompsonJames F ClarkNeil HawkinsMike ChambersBartolome CelliPeter Calverley Source Type: research
More News: Advair | Advair Diskus | Chronic Obstructive Pulmonary | Clinical Trials | Flonase | Flovent | Respiratory Medicine | Study